Glycoprotein B: Began Phase I trials

Chiron Corp. (CHIR), Emeryville, Calif. Product: Glycoprotein B (gB) subunit vaccine for cytomegalovirus (CMV), containing the human CMV protein and one of two adjuvants, alum or MF59, CHIR's microfl...